Statistical fragility of reporting hemidiaphragmatic paralysis after brachial plexus blocks in randomized controlled trials: a systematic review
- PMID: 40476887
- PMCID: PMC10123017
- DOI: 10.1007/s44254-023-00006-6
Statistical fragility of reporting hemidiaphragmatic paralysis after brachial plexus blocks in randomized controlled trials: a systematic review
Abstract
To characterize the fragility index (FI) of statistically significant results reported in randomized controlled trials (RCTs) investigating the incidence of hemidiaphragmatic paralysis (HDP) after brachial plexus blocks. A systematic review of RCTs retrieved from the PubMed-Medline, Embase, and Web of Science electronic databases was conducted. All alternative RCTs published between January 2012 and October 2022 were identified. Only RCTs with two parallel arms designs, and reporting HDP as the primary outcome, statistical significance, and superiority results were selected. The FI was calculated according to Fisher's exact test using previously described methods. In addition, the risk of bias was evaluated using the Cochrane Risk-of-Bias tool for randomized trials. The 23 RCTs that fulfilled the inclusion criteria had a median FI of 4 (interquartile range [IQR]2-8) and a median Fragility Quotient of 0.077 (IQR 0.038- 0.129). However, in 13 (56.5%) trials, the calculated FI value was ≤ 4. In 3/23 (13.0%) trials, the number of patients who dropped-out exceeded the FI value. Most trials (91.3%) had an overall low risk of bias. This systematic review revealed that the statistical results of RCTs investing HDP after brachial plexus blocks have tended to be fragile in the past decade. The FI should be an important aid in the interpretation of clinical results in combination with the P-value, particularly when statistically significant results are dependent on a small number of events. Future RCTs with larger sample sizes are needed to obtain more robust results in this field.
Keywords: Brachial plexus block; Fragility index; Hemidiaphragmatic paralysis; Randomized controlled trials.
© The Author(s) 2023.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures


Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are?BMC Complement Med Ther. 2024 Aug 14;24(1):300. doi: 10.1186/s12906-024-04561-8. BMC Complement Med Ther. 2024. PMID: 39143474 Free PMC article.
-
Fragility Analysis of Statistically Significant Outcomes of Randomized Control Trials in Spine Surgery: A Systematic Review.Spine (Phila Pa 1976). 2021 Feb 1;46(3):198-208. doi: 10.1097/BRS.0000000000003645. Spine (Phila Pa 1976). 2021. PMID: 32756285
-
Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials.Hormones (Athens). 2022 Dec;21(4):665-681. doi: 10.1007/s42000-022-00396-5. Epub 2022 Sep 21. Hormones (Athens). 2022. PMID: 36129664 Free PMC article.
-
The statistical fragility of vertebroplasty outcomes: A systematic review of randomized controlled trials.J Craniovertebr Junction Spine. 2025 Jan-Mar;16(1):26-33. doi: 10.4103/jcvjs.jcvjs_13_25. Epub 2025 Apr 1. J Craniovertebr Junction Spine. 2025. PMID: 40292175 Free PMC article. Review.
References
-
- Tignanelli CJ, Napolitano LM. The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care. JAMA Surg. 2019;154(1):74–9. 10.1001/jamasurg.2018.4318. - PubMed
-
- Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol. 2014;67(6):622–8. 10.1016/j.jclinepi.2013.10.019. - PubMed
-
- Feigl GC, Litz RJ, Marhofer P. Anatomy of the brachial plexus and its implications for daily clinical practice: regional anesthesia is applied anatomy. Reg Anesth Pain Med. 2020;45(8):620–7. 10.1136/rapm-2020-101435. - PubMed
-
- Cubillos J, Giron-Arango L, Munoz-Leyva F. Diaphragm-sparing brachial plexus blocks: a focused review of current evidence and their role during the COVID-19 pandemic. Curr Opin Anaesthesiol. 2020;33(5):685–91. 10.1097/ACO.0000000000000911. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous